Learn
More
Approved for Combination Use with solifenacin succinate*
*Marketed in the US as VESIcare®
Approved for Combination Use
For adults with overactive bladder symptoms of urgency, frequency and leakage, Myrbetriq® (mirabegron) is FDA-approved for use in combination with solifenacin succinate*. Ask your doctor if this combination treatment may be right for you.
*Marketed in the US as VESIcare®
Call for Savings: 1-855-984-6304
†Subject to eligibility. Restrictions may apply.

What is MYRBETRIQ?

MYRBETRIQ is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat the following symptoms due to a condition called overactive bladder:

  • Urge urinary incontinence: a strong need to urinate with leaking or wetting accidents
  • Urgency: a strong need to urinate right away
  • Frequency: urinating often

It is not known if MYRBETRIQ, when used alone or with solifenacin succinate, is safe and effective in children.

How should I take MYRBETRIQ?

  • If your doctor prescribes MYRBETRIQ and solifenacin succinate together, you should take 1 MYRBETRIQ tablet and 1 solifenacin tablet at the same time, 1 time a day.
  • You should take MYRBETRIQ with water and swallow the tablet whole.
  • Do not chew, break, or crush the tablet.
  • You can take MYRBETRIQ with or without food.
  • You can take MYRBETRIQ and solifenacin succinate together with or without food.

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include:

  • dry mouth
  • urinary tract infection
  • constipation
  • fast heartbeat

USE OF MYRBETRIQ

Myrbetriq® (mirabegron) is a prescription medicine for adults that can be used alone or with solifenacin succinate to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

IMPORTANT SAFETY INFORMATION FOR MYRBETRIQ

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®), or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

The most common side effects of MYRBETRIQ, when used with solifenacin succinate, include dry mouth, urinary tract infection, constipation, and fast heartbeat.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

USE OF VESICARE

VESIcare® (solifenacin succinate) is for overactive bladder with symptoms of urgency, frequency, and leakage.

IMPORTANT SAFETY INFORMATION FOR VESICARE

VESIcare is not for everyone. If you have certain stomach or glaucoma problems, or trouble emptying your bladder, do not take VESIcare. VESIcare may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat, or tongue, stop taking VESIcare and get emergency help. Tell your doctor right away if you have severe abdominal pain, or become constipated for three or more days. VESIcare may cause blurred vision, so use caution while driving or doing unsafe tasks. Common side effects are dry mouth, constipation, and indigestion.

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for VESIcare® (solifenacin succinate).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® and VESIcare® are registered trademarks of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

Get your first prescription at no cost! Subject to eligibility. Restrictions may apply. Not available to patients paying cash.

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Savings & Support

In this section, you'll learn about:

  • How eligible patients can save on their Myrbetriq prescription*
  • The Momentum Program with tips for managing OAB symptoms
  • Assistance for those
    who can't afford to pay for Myrbetriq

*Subject to availability.
Restrictions may apply.

Momentum Savings Card

If you're eligible, you can get your first prescription at no cost* and save up to $70 every month for a full year!

The Momentum Program offers savings for eligible patients being treated with Myrbetriq for their OAB symptoms. With the Momentum Savings Card, new patients may be able to receive their first month's prescription at no cost*, plus save a maximum of $840 for 12 uses on their Myrbetriq prescription.

The patient is responsible for the first $20 plus any differential over $90 for each individual prescription. Find out today if you are eligible. Please read the eligibility restrictions below.

Eligibility Restrictions

TO THE PATIENT: Patients paying cash are not eligible to receive the first prescription at no cost. This offer is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, CHAMPUS, Puerto Rico Government Health Insurance, or any State Patient or
Pharmaceutical Assistance Program. This offer is void where prohibited by law. Certain rules and restrictions apply.

*Subject to eligibility. Restrictions may apply.
Not available to patients paying cash.
Subject to eligibility. Restrictions may apply.

Enroll Now

A program designed to help you
start strong and stay on track

The Momentum Program was designed to support and encourage those taking Myrbetriq (mirabegron) with tips and tools that can help you on your treatment journey. Best of all, they are delivered right to your inbox or mailbox and include:

  • Doctor Conversation Guide – To start a dialogue with your doctor about your OAB symptoms
  • A starter package – Complete with
    easy‑to‑use trackers to chart your progress and informative tips to help you stick with the plan your doctor prescribed
  • Bladder-friendly recipes – Including foods to avoid, as they may irritate your bladder
  • Simple exercises – Tips on exercises
    you can do anytime, anywhere, to strengthen key muscles
  • Daily medication reminders – These can
    help you make taking your medication part of your routine

Want help with managing your OAB symptoms?
If you're covered under a government plan
(e.g., Medicaid or Medicare) and not eligible for savings, sign up to get helpful tips, tools, recipes and more!

Always talk with your doctor before starting any diet or exercise program.


Thank you for registering

Thank you for registering to receive emails from the Momentum Program. You can look forward to information, recipes, exercises, and tools to help you manage your OAB symptoms.


Patient Assistance

If you're concerned about paying
for Myrbetriq, we're here to help

You may be eligible to receive Myrbetriq at no cost. The Astellas Patient Assistance Program can determine if you are eligible for enrollment based on your insurance status and other criteria. To learn more, visit www.astellaspharmasupportsolutions.com

Astellas Pharma Support Solutions seeks to
help patients through the Astellas Patient Assistance Program, benefit verification, and the prior authorization process.

Contact Astellas Pharma Support Solutions at: www.astellaspharmasupportsolutions.com or 1‑800‑477‑6472
Monday – Friday 9 AM to 8 PM ET

Monday – Friday
9 AM to 8 PM ET

Currently taking Myrbetriq?
Share your OAB story.

Here's your chance to inspire others living with OAB symptoms. As a part of the MyGuide Network, you can share your experience to help educate, motivate, and provide new perspectives to others. To participate, simply give us a call toll‑free at 1‑844‑570‑5757.

The MyGuide Network is a volunteer network sponsored by Astellas Pharma US, Inc.

Next Section
Home
Prev Section
Getting Started

Use of Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to VITALS®.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide